UK pharma major AstraZeneca today released positive high-level results from the CAPItello-281 Phase III trial showing that ...
To combat antimicrobial resistance (AMR), the EU has introduced a transferable exclusivity voucher system, offering companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback